In a world rebuilding itself from the ground up, few visions feel as elemental — and as elegant — as TerraLux. At the ...

Discover why fitness experts are rethinking traditional crunches and explore 6 science-backed concerns that might change how ...

Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced ...

Third quarter results for REA Group largely met broker expectations as the market debates the impact of a new competitive ...

This study presents a valuable meta-analysis that highlights low and highly variable breast cancer survival rates across Africa, emphasizing the pressing need for public health in Africa. The evidence ...

It is an important development in effort to create a unified framework for measuring and reporting attention to media ...

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biotechnology company developing gene therapies for the treatment of inherited retinal diseases (IRDs) and other treatments for ophthalmic disorders ...